Best Hepatobiliary Specialists for Bile Duct Cancer / Cholangiocarcinoma in India
This page lists 27 bile duct cancer / cholangiocarcinoma doctors in India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
Quick answer
This page lists 27 bile duct cancer / cholangiocarcinoma doctors in India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Bile Duct Cancer / Cholangiocarcinoma doctors in India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
About the Condition
What is Bile Duct Cancer / Cholangiocarcinoma?
Cholangiocarcinoma, commonly known as bile duct cancer, is a malignancy that arises from the cells lining the bile ducts — the network of tubes that carries bile from the liver and gallbladder to the small intestine. It is considered a serious and often challenging diagnosis because tumours frequently grow without obvious symptoms in their early stages, meaning many cases are detected at an advanced point. Known risk factors include primary sclerosing cholangitis (PSC), chronic liver disease, hepatitis B or C infection, biliary duct anomalies, liver fluke infestation in certain regions, and long-standing bile duct stones. Establishing the extent of disease and the most appropriate course of care requires a thorough review of personal and family medical history alongside targeted investigations.
Individual assessmentEvery case is different
Complete evaluationUnderstand the condition first
Specialist reviewChoose the right approach
Medical assessment helps clarify severity and identify appropriate options.
Treatment options for Bile Duct Cancer / Cholangiocarcinoma
Care may include lifestyle changes, medical treatment, specialist review or a procedure, depending on the diagnosis, associated conditions and individual goals. The options below are associated with this condition in the GAF Healthcare directory.
Liver resection is a surgical procedure to remove a portion of the liver affected by primary liver cancer, metastatic tumors, or bile duct cancer (cholangiocarcinoma), while preserving enough healthy liver tissue to maintain normal function.
Why it may be consideredIt is often the most effective curative option for localized liver tumors and can be performed via open surgery or minimally invasive techniques depending on tumor size, location, and patient fitness. India's leading HPB centers offer this procedure with outcomes comparable to Western hospitals at a fraction of the cost.
Bile duct surgery involves the surgical removal of tumors or diseased segments of the bile duct system, often combined with partial liver resection, to treat bile duct cancer (cholangiocarcinoma) or severe bile duct strictures.
Why it may be consideredThe goal is to achieve complete tumor clearance while restoring normal bile flow through reconstruction of the biliary tract. It is typically performed by a specialized hepato-pancreato-biliary (HPB) surgical team after thorough imaging and staging.
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
Many international patients consider India for bile duct cancer / cholangiocarcinoma treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
How this directory is built
Doctors are matched using the specialty, location, condition (Bile Duct Cancer / Cholangiocarcinoma) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.
Common questions
FAQs about Bile Duct Cancer / Cholangiocarcinoma in India
What is Bile Duct Cancer / Cholangiocarcinoma?
Bile duct cancer (cholangiocarcinoma) is a cancer that originates in the epithelial cells of the bile ducts, and it can occur within the liver (intrahepatic), at the junction where the liver's left and right ducts meet (perihilar, also called Klatskin tumour), or in the lower part of the duct closer to the small intestine (distal). It is classified and staged — typically using the TNM system or location-specific staging criteria — to guide treatment planning.
What are the symptoms and health risks of Bile Duct Cancer / Cholangiocarcinoma?
Common presentations include painless jaundice (yellowing of the skin and eyes), dark urine, pale stools, persistent itching, unintentional weight loss, abdominal discomfort, and fatigue — all of which can also occur with other biliary or liver conditions. Some individuals, particularly those with intrahepatic tumours, may have no symptoms at all until the disease is at an advanced stage. These symptoms should prompt medical evaluation, but they do not on their own confirm a diagnosis of cholangiocarcinoma.
How is Bile Duct Cancer / Cholangiocarcinoma diagnosed?
Diagnosis typically begins with blood tests including liver function tests and tumour markers such as CA 19-9 and CEA, though these markers are not definitive on their own. Cross-sectional imaging — such as contrast-enhanced CT, MRI with MRCP (magnetic resonance cholangiopancreatography), or endoscopic ultrasound — is used to characterise the tumour's location, size, and relationship to surrounding structures. Tissue confirmation through biopsy or biliary brushings during endoscopic or percutaneous procedures, combined with staging to assess lymph node involvement and distant spread, is usually necessary before a treatment plan is finalised.
How is Bile Duct Cancer / Cholangiocarcinoma treated?
Treatment is highly individualised and depends on tumour location, stage, the patient's overall health, and liver function. For resectable tumours, surgical removal — such as liver resection or bile duct surgery — offers the best prospect of long-term disease control and is the primary curative option; in selected cases of intrahepatic cholangiocarcinoma, liver transplantation may be considered within specific clinical protocols. For unresectable or metastatic disease, systemic chemotherapy (commonly gemcitabine-based regimens), targeted therapies for tumours with specific molecular alterations (such as FGFR2 fusions or IDH1 mutations), and biliary drainage procedures to relieve obstruction form the mainstays of care.
Can Bile Duct Cancer / Cholangiocarcinoma be treated without surgery?
When the tumour is not amenable to surgery — due to extent of disease, involvement of critical vascular structures, or the patient's fitness — chemotherapy, immunotherapy, and molecularly targeted agents represent meaningful treatment pathways that can slow progression and improve quality of life. Biliary stenting or external drainage may also be performed to relieve jaundice and reduce infection risk regardless of whether curative treatment is pursued. That said, for patients who are surgical candidates, non-surgical management alone is generally not considered curative, and the decision between approaches depends entirely on individual clinical assessment.
When is Liver Resection considered for Bile Duct Cancer / Cholangiocarcinoma?
Liver Resection may be considered when conservative or medical options have not achieved enough improvement, or when the severity of the condition warrants it. The decision depends on clinical assessment, expected benefits and individual risks.
Which doctor treats Bile Duct Cancer / Cholangiocarcinoma?
Cholangiocarcinoma is typically evaluated and managed by a hepatobiliary (HPB) surgeon working in close collaboration with a specialist hepatologist or gastroenterologist, a medical oncologist, and an interventional radiologist or endoscopist — ideally through a dedicated multidisciplinary team (MDT). In cases where liver transplantation is being considered, a transplant hepatologist and transplant surgeon become integral to the team.
How do I choose a doctor for Bile Duct Cancer / Cholangiocarcinoma?
When selecting a centre or specialist for cholangiocarcinoma, it is worth prioritising institutions with a high-volume HPB surgery programme, demonstrated experience with complex biliary reconstructions, and access to a formal multidisciplinary tumour board that includes oncology, radiology, and pathology. Ask about the team's specific case volume for cholangiocarcinoma, availability of molecular tumour profiling, and what follow-up and surveillance protocols are in place after treatment.
What documents do international patients need to share for a medical evaluation?
Share a medical summary, investigation and imaging or biopsy reports where relevant, a current medication list, previous diagnoses and related treatment records. Provide clear copies with translation where needed.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team helps review initial medical information, connect you with suitable doctors and hospitals, explain next steps and indicative estimates, and organise a treatment plan before travel.
